Theriva Biologics, Inc. (TOVX)
0.196
+0.01
(+3.16%)
USD |
NYAM |
Oct 23, 16:00
0.1916
0.00 (0.00%)
After-Hours: 20:00
Theriva Biologics Price to Book Value : 0.7381 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 0.7381 |
| October 22, 2026 | 0.7155 |
| October 21, 2026 | 0.7404 |
| October 20, 2026 | 0.7833 |
| October 19, 2026 | 0.7709 |
| October 16, 2026 | 0.7829 |
| October 15, 2026 | 0.7983 |
| October 14, 2026 | 0.7904 |
| October 13, 2026 | 0.8123 |
| October 12, 2026 | 0.8262 |
| October 09, 2026 | 0.8172 |
| October 08, 2026 | 0.8552 |
| October 07, 2026 | 0.8812 |
| October 06, 2026 | 0.836 |
| October 05, 2026 | 0.8473 |
| October 02, 2026 | 0.8477 |
| October 01, 2026 | 0.8473 |
| September 30, 2026 | 0.8473 |
| September 29, 2026 | 0.7908 |
| September 28, 2026 | 0.8153 |
| September 25, 2026 | 0.8307 |
| September 24, 2026 | 0.868 |
| September 23, 2026 | 0.8838 |
| September 22, 2026 | 0.8691 |
| September 21, 2026 | 0.8691 |
| Date | Value |
|---|---|
| September 18, 2026 | 0.8793 |
| September 17, 2026 | 0.9113 |
| September 16, 2026 | 0.8511 |
| September 15, 2026 | 0.8477 |
| September 14, 2026 | 0.8872 |
| September 11, 2026 | 0.9324 |
| September 10, 2026 | 0.914 |
| September 09, 2026 | 0.9377 |
| September 08, 2026 | 0.9305 |
| September 04, 2026 | 0.9527 |
| September 03, 2026 | 0.9527 |
| September 02, 2026 | 0.9343 |
| September 01, 2026 | 0.9377 |
| August 31, 2026 | 0.9414 |
| August 28, 2026 | 0.923 |
| August 27, 2026 | 0.9509 |
| August 26, 2026 | 0.9158 |
| August 25, 2026 | 0.8944 |
| August 24, 2026 | 0.8853 |
| August 21, 2026 | 0.885 |
| August 20, 2026 | 0.8669 |
| August 19, 2026 | 0.8488 |
| August 18, 2026 | 0.8492 |
| August 17, 2026 | 0.8947 |
| August 14, 2026 | 0.8586 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.599 |
| Alnylam Pharmaceuticals, Inc. | 22.13 |
| Anika Therapeutics, Inc. | 2.088 |
| Savara, Inc. | 6.034 |
| Vericel Corp. | 5.881 |
Price to Book Value Related Metrics
| PS Ratio | 21.61 |
| Price | 0.196 |
| Earnings Yield | -341.2% |
| Market Cap | 8.995M |